Das, N. A., Carpenter, A. J., Belenchia, A., Aroor, A. R., Noda, M., Siebenlist, U., . . . DeMarco, V. G. (2019). Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-tomesenchymal transition. Cell Signal.
استشهاد بنمط شيكاغوDas, Nitin A., Andrea J. Carpenter, Anthony Belenchia, Annayya R. Aroor, Makoto Noda, Ulrich Siebenlist, Bysani Chandrasekar, و Vincent G. DeMarco. "Empagliflozin Reduces High Glucose-induced Oxidative Stress and MiR-21-dependent TRAF3IP2 Induction and RECK Suppression, and Inhibits Human Renal Proximal Tubular Epithelial Cell Migration and Epithelial-tomesenchymal Transition." Cell Signal 2019.
MLA استشهادDas, Nitin A., et al. "Empagliflozin Reduces High Glucose-induced Oxidative Stress and MiR-21-dependent TRAF3IP2 Induction and RECK Suppression, and Inhibits Human Renal Proximal Tubular Epithelial Cell Migration and Epithelial-tomesenchymal Transition." Cell Signal 2019.